3Commas Unveils QuantPilot, Targeting Retail Traders With Institutional-Style AI Tools

Early Access Now Available for Advanced Traders — Sign Up for the QuantPilot Waiting List: quantpilot.com Tallin, Estonia, 3rd April 2026,  —3Commas, a crypto trading automation provider, introduced QuantPilot, an AI-driven platform designed to streamline the development and execution of quantitative trading strategies. The company opened a waiting list for Read more

April 3, 2026|

Faiz Chowdhury Calls for an Impact-Driven Technology Economy

California, USA, 2nd April 2026, ZEX PR WIRE, Technology has reshaped nearly every part of modern life. Yet global challenges remain urgent. More than 700 million people still live in extreme poverty. Roughly 675 million lack access to electricity. Over 2 billion people do not have safely managed drinking water. Climate-related disasters Read more

April 2, 2026|

New Paper in Translational Insights Presents a Unifying Theory for How the Immune System Recognizes Cancer

Nashville, TN, 2nd April 2026, ZEX PR WIRE — TAM Global today announced the publication of a new peer-reviewed paper in Translational Insights led by Chief Scientific Officer Dr. Francesco M. Marincola and collaborators from TAM Biosciences. The paper, The Perfect Storm: Viral Mimicry Meets Cancer Dark Matter, presents a novel, unifying theory explaining how the immune system Read more

April 2, 2026|

Conflux Joins Hong Kong Web3 Festival as Secondary Exhibition Sponsor

Hong Kong, 2nd April 2026, ZEX PR WIRE — Hong Kong Web3 Festival 2026 is honored to welcome Conflux as a Secondary Exhibition Sponsor. Conflux builds the L1 infrastructure for seamless payments, global remittances, and decentralized finance. More: https://confluxnetwork.org/zh Hong Kong Web3 Festival (“Web3 Festival”), co-hosted by Wanxiang Blockchain Labs and HashKey Group, is Read more

April 2, 2026|

Lupin Completes Acquisition of VISUfarma

MUMBAI, India and LONDON and ROME and ZUG, Switzerland, 2nd April 2026, ZEX PR WIRE — Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). Read more

April 2, 2026|
Go to Top